Vice President Clinical Development at RAPT Therapeutics, Inc.
Redwood City, California, United States
AbbVie
Senior Medical Director, Oncology Clinical Development
April 2015 to Present
Gilead Sciences
Director, Clinical Research, Oncology/Inflammation
July 2011 to March 2015
University of California Santa Cruz, Extension Silicon Valley
Clinical Trials Design and Managing
January 2011 to June 2011
Hannover Medical School, Germany
Doctorate
September 2009 to November 2010
Stanford University School of Medicine
Instructor of Pediatrics
June 2006 to October 2009
University of Southern California Keck School of Medicine
Assistant Professor
July 2003 to June 2006
Children's Hospital Los Angeles (CHLA)
Postdoctoral Fellow
August 2000 to June 2003
Technische Universität München, Klinikum rechts der Isar
Resident Physician and Research Fellow
March 1998 to July 2000
University Hospital Medical Center
Physician in Training (Arzt im Praktikum)
1996 to 1998
Stanford University School of Medicine
Instructor Pediatrics
2006 to 2009
Keck School of Medicine of the University of Southern California
Postdoctoral Fellow Immunology
2000 to 2003
University of California, Santa Cruz
Certificate Clinical Trials Design and Management
Medizinische Hochschule Hannover
Doctorate (Doctor Medicinae Dr. med.) Hematology/Immunology
The University of Göttingen
M.D. Medicine
1988 to 1996
Friedrichsgymnasium Kassel
Abitur/Baccalaureate Gymnasium (High School) Classical education
1977 to 1986
What company does Thomas Jahn work for?
Thomas Jahn works for AbbVie
What is Thomas Jahn's role at AbbVie?
Thomas Jahn is Senior Medical Director, Oncology Clinical Development
What industry does Thomas Jahn work in?
Thomas Jahn works in the Pharmaceuticals industry.
Who are Thomas Jahn's colleagues?
Thomas Jahn's colleagues are Luc MG Briand, William Ho, Christophe C., and Christopher Overton
📖 Summary
- Licensed and trained physician (Germany), focus hematology/oncology - 4+ ys of experience in clinical development of targeted therapy for hematologic malignancies incl. filing and approval - P1/2/3 planning, protocols design, trial initialization including organization/execution of SIVs/investigator meetings - Medical monitoring of P1(b), pivotal P3 trials, and expanded access program - Responsible for P1/2/3 data integrity, interpretation and display for internal and external presentation (see referenced abstracts below) - Review of/input on/author of regulatory filing documents - Confident and cogent presenter of scientific data and representative of clinical development programs - Strong leadership, managing, problem solving and teaching skills - 6+ ys of experience as an academic group leader (Stanford University and University of Southern California) - Detailed clinical knowledge of and significant scientific contribution to oncologic paradigm diseases - Member of multiple professional clinical/translational research organizations (American Society of Clinical Oncology, Society of Pediatric Research, American Society of Hematology, American Association for Cancer Research); speaker, presenter, attendee at numerous national and international conferences - Excellent English and German scientific writing and presentation skills, basic French Major Areas of clin. research and clin. expertise • P1/2/3 clinical development • Internal Medicine, Hematology/Oncology • Leukemia/Lymphoma, CML, CLL, iNHL, AML Major Areas of Research Expertise • Disease mechanisms and target definition in oncogenesis • Hematological and immunological defects • Small molecule inhibitors and gene therapy • Signal transduction mechanisms in stem cells and cancer stem cellsSenior Medical Director, Oncology Clinical Development @ Clinical development of bcl-2 family inhibitors From April 2015 to Present (9 months) Director, Clinical Research, Oncology/Inflammation @ Clinical development of PI3-Kinase (PI3K) inhibitors (Phase 1/2/3) From July 2011 to March 2015 (3 years 9 months) Clinical Trials Design and Managing @ Continuing education and classes in • Good Clinical Practice, • Clinical Site Monitoring, • Drug Development, • Science of Clinical Trials Design http://www.ucsc-extension.edu/programs/clinical-trials From January 2011 to June 2011 (6 months) Doctorate @ Cumulative doctorate thesis in hematology/oncology Hannover Medical School, Hannover, Germany From September 2009 to November 2010 (1 year 3 months) Instructor of Pediatrics @ Department of Pediatrics, Division of Stem Cell Transplantation, Stanford University Medical School, Stanford, CA, USA From June 2006 to October 2009 (3 years 5 months) Assistant Professor @ Division of Research Immunology/Bone Marrow Transplantation, Children’s Hospital Los Angeles, Department of Pediatrics, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA From July 2003 to June 2006 (3 years) Postdoctoral Fellow @ Division of Research Immunology/Bone Marrow Transplantation, Children’s Hospital Los Angeles, Department of Pediatrics, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA From August 2000 to June 2003 (2 years 11 months) Resident Physician and Research Fellow @ Dept. of Internal Medicine, Hematology/Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany From March 1998 to July 2000 (2 years 5 months) Physician in Training (Arzt im Praktikum) @ Dept. of Internal Medicine III, Hematology/Oncology, University Hospital Medical Center, University of Ulm, Ulm, Germany From 1996 to 1998 (2 years) Instructor, Pediatrics @ Stanford University School of Medicine From 2006 to 2009 Postdoctoral Fellow, Immunology @ Keck School of Medicine of the University of Southern California From 2000 to 2003 Certificate, Clinical Trials Design and Management @ University of California, Santa CruzDoctorate (Doctor Medicinae, Dr. med.), Hematology/Immunology @ Medizinische Hochschule HannoverM.D., Medicine @ The University of Göttingen From 1988 to 1996 Abitur/Baccalaureate, Gymnasium (High School), Classical education @ Friedrichsgymnasium Kassel From 1977 to 1986 Thomas Jahn is skilled in: Clinical Research Experience, Molecular Medicine, Hematology, Leukemia, Cell Signaling, Drug Development, Oncology, Clinical Study Design, Data Analysis, Medicine, Clinical Research, Translational Research, Clinical Development, Cell
Introversion (I), Intuition (N), Feeling (F), Judging (J)
2 year(s), 2 month(s)
Unlikely
Likely
There's 86% chance that Thomas Jahn is seeking for new opportunities
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 400K users from
76% of Fortune 500 companies
The most accurate data ever
Hire Anyone, Anywhere
with ContactOut today
Making remote or global hires? We can help.
No credit card required